Encompass Health Corporation (EHC) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY25 Guidance

Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $1.17, $0.14 better than the analyst estimate of $1.03. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.38 billion.

GUIDANCE:

Encompass Health Corporation sees FY2025 EPS of $4.67-$4.96, versus the consensus of $4.77. Encompass Health Corporation sees FY2025 revenue of $5.8-5.9 billion, versus the consensus of $5.83 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Active options: NVDA TSLA MU SPCX AAPL AMZN MSFT META INTC
• Enovix Corporation (ENVX) PT Lowered to $10 at Cantor Fitzgerald